Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mural Oncology plc | Chief Financial Officer | Stock Option (right to buy) | 146K | $491K | $3.35 | Dec 14, 2023 | Direct |
Mural Oncology plc | Chief Financial Officer | Ordinary Shares | 71.4K | $244K | $3.41 | Oct 31, 2024 | Direct |
InMed Pharmaceuticals Inc. | Director | Employee Stock Option (Expiration) | 16.1K | Jan 24, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MURA | Mural Oncology plc | Oct 31, 2024 | 1 | -$25.3K | 4 | Nov 1, 2024 | Chief Financial Officer |
MURA | Mural Oncology plc | Dec 14, 2023 | 2 | $0 | 4 | Dec 18, 2023 | Chief Financial Officer |
MURA | Mural Oncology plc | Nov 15, 2023 | 0 | $0 | 3 | Nov 15, 2023 | Chief Financial Officer |
INM | InMed Pharmaceuticals Inc. | Jan 24, 2022 | 3 | $0 | 4 | Jan 24, 2022 | Director |
INM | InMed Pharmaceuticals Inc. | Dec 29, 2021 | 1 | $0 | 4 | Dec 30, 2021 | Director |